CGEN vs VRTX: Which Stock is Better?

Side-by-side comparison of Compugen Ltd and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

CGEN

Compugen Ltd

$2.83

VRTX

Vertex Pharmaceuticals Inc

$435.10

Key Metrics Comparison

MetricCGENVRTXWinner
Market Cap$269.72M$111.33BVRTX
P/E Ratio7.4728.57CGEN
EPS (TTM)$0.38$15.32VRTX
Revenue Growth44.8%0.1%CGEN
Gross Margin87.3%53.7%CGEN

Analyze CGEN

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CGEN or VRTX a better investment?

Comparing CGEN and VRTX: Compugen Ltd has a market cap of $269.72M while Vertex Pharmaceuticals Inc has $111.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CGEN and VRTX?

CGEN (Compugen Ltd) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CGEN or VRTX?

Based on P/E ratios, CGEN trades at a lower multiple (7.5x vs 28.6x).

Which is growing faster: CGEN or VRTX?

CGEN has higher revenue growth at 44.8% vs 0.1% for VRTX.

Which company is more profitable: CGEN or VRTX?

Compugen Ltd (CGEN) has higher gross margins at 87.3% compared to 53.7% for VRTX.

Which is the larger company: CGEN or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $111.33B compared to $269.72M for CGEN.

Should I buy CGEN or VRTX in 2026?

Both CGEN and VRTX have investment merit. CGEN trades at $2.83 while VRTX trades at $435.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CGEN and VRTX stock?

Key differences: Market Cap ($269.72M vs $111.33B), P/E Ratio (7.5x vs 28.6x), Revenue Growth (44.8% vs 0.1%), Gross Margin (87.3% vs 53.7%).

Popular Stock Comparisons